KUMAR NEIL (See Remarks) sold 1.8% of their position (80K shares) of BRIDGEBIO PHARMA, INC. on the open market
Open‑market sale worth $5.50M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
−14.34K
Price / share
$68.48
Trade value
$981.81K
% of position
Common Stock
Shares
−5.36K
Price / share
$69.32
Trade value
$371.75K
% of position
Common Stock
Shares
−300.00
Price / share
$70.15
Trade value
$21.05K
% of position
Common Stock
Shares
−13.88K
Price / share
$68.47
Trade value
$950.69K
% of position
Common Stock
Shares
−5.82K
Price / share
$69.29
Trade value
$402.93K
% of position
Common Stock
Shares
−300.00
Price / share
$70.15
Trade value
$21.05K
% of position
Common Stock
Shares
−9.69K
Price / share
$68.36
Trade value
$662.44K
% of position
Common Stock
Shares
−10.31K
Price / share
$69.20
Trade value
$713.45K
% of position
Common Stock
Shares
−10.24K
Price / share
$68.39
Trade value
$700.35K
% of position
Common Stock
Shares
−9.76K
Price / share
$69.23
Trade value
$675.57K
% of position
Net shares
−80K
Net value
-$5.50M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 3/12/2026 | S · Sale | −14.34K | $68.48 | $981.81K | 2.1% | 675.69K | 661.35K |
| Common Stock Indirect | 3/12/2026 | S · Sale | −5.36K | $69.32 | $371.75K | 0.8% | 661.35K | 655.99K |
| Common Stock Indirect | 3/12/2026 | S · Sale | −300.00 | $70.15 | $21.05K | 0.0% | 655.99K | 655.69K |
| Common Stock Indirect | 3/12/2026 | S · Sale | −13.88K | $68.47 | $950.69K | 0.3% | 4.48M | 4.46M |
| Common Stock Indirect | 3/12/2026 | S · Sale | −5.82K | $69.29 | $402.93K | 0.1% | 4.46M | 4.46M |
| Common Stock Indirect | 3/12/2026 | S · Sale | −300.00 | $70.15 | $21.05K | 0.0% | 4.46M | 4.46M |
| Common Stock Indirect | 3/13/2026 | S · Sale | −9.69K | $68.36 | $662.44K | 1.5% | 655.69K | 646K |
| Common Stock Indirect | 3/13/2026 | S · Sale | −10.31K | $69.20 | $713.45K | 1.6% | 646K | 635.69K |
| Common Stock Indirect | 3/13/2026 | S · Sale | −10.24K | $68.39 | $700.35K | 0.2% | 4.46M | 4.45M |
| Common Stock Indirect | 3/13/2026 | S · Sale | −9.76K | $69.23 | $675.57K | 0.2% | 4.45M | 4.44M |
| Total | −80K | -$5.50M | ||||||
Common Stock
Direct| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 234.45K | Direct |
| Total | 234.45K | 234.45K direct |